Today's News: Middle East
SEE OTHER BRANDS

Following the news from the Middle East

Today's News: Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.

Press releases published on August 13, 2025

MacroGenics Appoints Eric Risser as President and Chief Executive Officer
Elcora Provides Update on Status of Management Cease Trade Order
The Journey To Nature by Musa Temel Wins Bronze in A' Interior Design Awards
Emerita Announces Upsize to C$25M Brokered Private Placement Financing
ARABLAB LIVE 2025 to Bring Global Laboratory Innovations to Dubai
Clean Energy Market to Hit $1.4 Trillion by 2032 | 9.1% CAGR Fuels Growth
Little Pepe (LILPEPE) Presale Hits $19,325,000 as Investors Snap Up 12.75 Billion Tokens to End Stage 10 Early
Explorer Events Expands from Team Building to Full-Scale Corporate Event Management in Dubai
Dundee Precious Metals Announces Overwhelming Shareholder Approval for Acquisition of Adriatic Metals and Name Change
Terra Balcanica Closes Fully Subscribed LIFE Offering
Rising Demand in Agriculture & Energy Diversification to Boost UAE LPG Market
Mulch Week: Green Zen Busts Common Myths and Calls for Smarter Landscaping Across the UAE
Erdem Hospital Performs First-of-Its-Kind Spinal Revision Surgery
K10 Vision Highlights Exceptional Customer Service as it Expands Rapidly in the North American University Sector
It’s Happening: Danger Globe to Launch ‘Globe of Death’ Motorcycle Stunt Show in Dubai
Saudia Recognized as ‘Best in Class for Service-Guest Experience’ by APEX World Class Airlines
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain
24/7 Market News: LIXTE Biotechnology Holdings Embraces Cryptocurrency in Corporate Treasury Strategy
MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers
Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions